{"name":"Cook MyoSite","slug":"cook-myosite","ticker":"","exchange":"","domain":"cookmyosite.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AMDC-USR (iltamiocel)","genericName":"AMDC-USR (iltamiocel)","slug":"amdc-usr-iltamiocel","indication":"Acute myocardial infarction with left ventricular dysfunction","status":"phase_3"}]}],"pipeline":[{"name":"AMDC-USR (iltamiocel)","genericName":"AMDC-USR (iltamiocel)","slug":"amdc-usr-iltamiocel","phase":"phase_3","mechanism":"AMDC-USR (iltamiocel) is an autologous skeletal myoblast cell therapy that regenerates damaged heart muscle tissue following myocardial infarction.","indications":["Acute myocardial infarction with left ventricular dysfunction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQZ1pHWUpBTmJyVDZDNXpwWnhQbzhlQUtkcjgwTGppOEVydUxXekZvSGJKOGhOOGJEc0NVVU5mZ1AyaFF4Q3lGdDMtbkV5TUotcEZOMWJhdzhDbXRfaTREWW5WREpPMlFLQlJrVi1pd0RQVjBGbnppZW9zN19SZlE0RW40a0x3OTRXU2RKbUNsUVQwS2Y4Q2pOalNHQ0dWWHpmbkdJa09mTQ?oc=5","date":"2025-06-26","type":"pipeline","source":"The Business Journals","summary":"Lipella Pharmaceuticals delisted from Nasdaq, explores relisting options amid ongoing operations - The Business Journals","headline":"Lipella Pharmaceuticals delisted from Nasdaq, explores relisting options amid ongoing operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1ySDV1YlE0X1IzSmZDNWsyRUR1b0pwVUtSWTNIQVFjYWdvbUg4RWw3Qlg5b0RMQ1JmQkxfRWtWV0V2QnV6bWJCWmk4ODFKQnlEcFk3b0V2anJOdUU3aThCSdIBZkFVX3lxTE5XakdFMWdTY3Y3SDJaa0haS3QxU0p2clM1ZlBwRWxjd3c2RnJYRWt0eHYzVjduS2pSR0lpdU5fb2VtYlQzc19VdnluUXFXaDZKNDB5bUloQ1BldGdmbFR5dnhqQnA3dw?oc=5","date":"2025-05-01","type":"deal","source":"BioInformant","summary":"Curi Bio and Cook MyoSite Announce Strategic Partnership - BioInformant","headline":"Curi Bio and Cook MyoSite Announce Strategic Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVU4yRmRJcmVfT3RRT0F1WFA2aHlvUFA0UmtUSWVuLVNHb290OVpMaGtzclZRMVdLdzFmOE44RmtndzBFRHJBZVdkUGRiWUdWMmdYVnNJYmJlU2M2WnZ6Qkg2bVZjOGVwWFlJd1dsZER6ZU5BMHpSOWdFLWRQemxreWh0MF9ibC1xYmlGTEN0VDlFZ1E3bEdCY2NHOHpLa01VTUpMc3ZpeU5wWWF2bnlYQjVlb3U?oc=5","date":"2023-05-15","type":"earnings","source":"BioSpace","summary":"Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update - BioSpace","headline":"Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zNUtSTHRWSC15YUJ4YjB5UlR1VmxfRy1MbkQ5LVQ5TUxJdVk1Sm1HU0wzUDdja0VQZTdzRFJMVC13cDhuUkNMUXM1bWc0YXZ2bHdLZ2Y3eWRfNmFjbWxr?oc=5","date":"2021-06-27","type":"pipeline","source":"Nature","summary":"Manufacturing consistent, high-quality muscle cell products - Nature","headline":"Manufacturing consistent, high-quality muscle cell products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1ybVRiQ1hvaXppR1pGLW9sRGZYQ1JlZzdtOHFvVThvdjNKTUpMYU44d2dTT09VU2xwSjU4aUxaUVlFc3hodHA4ZVdyZ1VqMmlQSGZJdHRB0gFbQVVfeXFMT2JDWjR1SFpaQWpYWHRmLXpLSnMtaW9mSkhNSnFmazF1LVhVeVhTRXY0eVdJR1RNWUpjY3NNMmQwWk1lTUJENGs5SjEyWmhIUFk4T2FXT0kyZ1Y2Zw?oc=5","date":"2020-12-17","type":"regulatory","source":"BioInformant","summary":"FDA Grants RMAT Designation for Cook MyoSite’s Investigational Autologous Muscle Derived Cells for Urinary Sphincter Repair - BioInformant","headline":"FDA Grants RMAT Designation for Cook MyoSite’s Investigational Autologous Muscle Derived Cells for Urinary Sphincter Rep","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNVEVVOHE1TkdzeV9rMEhRSzhuX01LY08tdXQwd0xyVE5hTkYzYUMtOGdTRkVuQUFhMm9EN0xDcVVOdzdTdVNwRGRSMS1ldmYtSk42NmpKT3UwUkhRUm00bVRFYy1hdzBOZE9GTDh1YVlxcnA0TFYxd0VvWWRnN1lhb05rRTg3eUJfQ1Z6QW1YSVY5VVg3b2FjUW9kRXBrdWFScG5NQV8zRVJ0M045N29wOWl5ZU9maVZGaW91bg?oc=5","date":"2016-08-06","type":"pipeline","source":"The Herald-Times","summary":"Carl Cook inherited his father's company — and his vision - The Herald-Times","headline":"Carl Cook inherited his father's company — and his vision - The Herald","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5WZHgwT3lwMVd2bl93bUw2ck1NaEZBM3M5UHFLbURnOWVveUNwLUpaLVJIWHJZSUpuT1hEcXlnLUZmc2lyZXduYW9YSkZQNjNseFc4?oc=5","date":"2016-07-27","type":"pipeline","source":"Forbes","summary":"Carl Cook - Forbes","headline":"Carl Cook","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":8,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}